A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1089-1094

  Bandrés, Eva ^a   Malumbres, Raquel ^a   Cubedo, Elena ^a   Honorato, Beatriz ^a   Zarate, Ruth ^a   Labarga, Alberto ^b   Gabisu, Unai ^b   Sola, Jesús Javier ^c   García Foncillas, Jesús ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Polígono Mocholí   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Colonic neoplasms; Disease progression; Oligonucleotide array; Recurrence; Sequence analysis; Tumor markers

Indexed keywords

AGED; ARTICLE; CANCER STAGING; COLON TUMOR; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIGENE FAMILY; PATHOLOGY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

AGED; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 34548557220     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1089     Document Type: Article

References (30)

1. Saha D, Roman C and Beauchamp RD: New strategies for colorectal cancer prevention and treatment. World J Surg 26: 762-766, 2002. (Pubitemid 36920314)
2. Becker H: Surgery of colorectal carcinoma. Schweiz Rundsch Med Prax 84: 1371-1372, 1995.
3. MacDonald JS: Adjuvant therapy of colon cancer. CA Cancer J Clin 49: 202-219, 1999.
4. Graziano F and Cascinu S: Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann Oncol 14: 1026-1038, 2003. (Pubitemid 36950166)
5. Buyse M and Piedbois P: Should Dukes' B patients receive adjuvant therapy? A statistical perspective. Semin Oncol (Suppl 1): 20-24, 2001. (Pubitemid 32173100)
6. McLeod HL and Murray GI: Tumour markers of prognosis in colorectal cancer. Br J Cancer 79: 191-203, 1999. (Pubitemid 29002285)
7. Schena M, Shalon D, Davis RW and Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470, 1995.
8. Bertucci F, Salas S, Eysteries S, et al: Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23: 1377-1391, 2004. (Pubitemid 38406833)
9. Wang Y, Jatkoe T, Zhang Y, et al: Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22: 1564-1571, 2004. (Pubitemid 41079793)
10. Iizuka N, Oka M, Yamada-Okabe H, et al : Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 361: 923-929, 2003. (Pubitemid 36332108)
11. Kooperberg C, Fazzio TG, Delrow JJ and Tsukiyama T: Improved background correction for spotted DNA microarrays. J Comput Biol 9: 55-66, 2002. (Pubitemid 34264286)
12. Troyanskaya O, Cantor M, Sherlock G, et al : Missing value estimation methods for DNA microarrays. Bioinformatics 17: 520-525, 2001. (Pubitemid 32600498)
13. Bolstad BM, Irizarry RA, Astrand M and Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193, 2003. (Pubitemid 36181903)
14. Barrett T, Suzek TO, Troup DB, et al: NCBI GEO: mining millions of expression profiles - database and tools. Nucleic Acids Res 33 (database issue): D562-D566, 2005.
15. Dudoit S, Shaffer JP and Boldrick JC: Multiple hypothesis testing in microarray experiments. Stat Sci 18: 71-103, 2003. (Pubitemid 41461823)
16. Lee SI and Batzoglou S: Application of independent component analysis to microarrays. Genome Biol 4: R76, 2003.
17. Everitt B: Cluster analysis: Heinemann Educ, 1974.
18. Kent WJ: BLAT - the BLAST-like alignment tool. Genome Res 12: 656-664, 2002.
19. Ning Z, Cox AJ and Mullikin JC: SSAHA: a fast search method for large DNA databases. Genome Res 11: 1725-1729, 2001. (Pubitemid 33040499)
20. Pray-Grant MG, Daniel JA, Schieltz D, Yates JR III and Grant PA: Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature 433: 434-438, 2005. (Pubitemid 40203325)
21. Tai HH, Geisterfer M, Bell JC, et al : CHD1 associates with NCoR and histone deacetylase as well as with RNA splicing proteins. Biochem Biophys Res Commun 308: 170-176, 2003. (Pubitemid 36904137)
22. Merchant JL, Iyer GR, Taylor BR, et al: ZBP-89, a Kruppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Mol Cell Biol 16: 6644-6653, 1996. (Pubitemid 26389722)
23. Passantino R, Antona V, Barbieri G, et al: Negative regulation of beta enolase gene transcription in embryonic muscle is dependent upon a zinc finger factor that binds to the G-rich box within the muscle-specific enhancer. J Biol Chem 273: 484-494, 1998. (Pubitemid 28042236)
24. Reizis B and Leder P: Expression of the mouse pre-T cell receptor alpha gene is controlled by an upstream region containing a transcriptional enhancer. J Exp Med 189: 1669-1678, 1999. (Pubitemid 29240892)
25. Law DJ, Tarle SA and Merchant JL: The human ZBP-89 homolog, located at chromosome 3q21, represses gastrin gene expression. Mamm Genome 9: 165-167, 1998. (Pubitemid 28165388)
26. Bai L and Merchant JL: ZBP-89 promotes growth arrest through stabilization of p53. Mol Cell Biol 21: 4670-4683, 2001. (Pubitemid 32588249)
27. Chen GG, Merchant JL, Lai PB, et al : Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89. Am J Pathol 162: 1823-1829, 2003. (Pubitemid 36613041)
28. Jin A, Itahana K, O'Keefe K and Zhang Y: Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 24: 7669-7680, 2004. (Pubitemid 39121492)
29. Frigerio JM, Dagorn JC and Iovanna JL: Cloning, sequencing and expression of the L5, L21, L27a, L28, S5, S9, S10 and S29 human ribosomal protein mRNAs. Biochim Biophys Acta 1262: 64-68, 1995.
30. Wu H, Liu G, Li C and Zhao S: bri3, a novel gene, participates in tumor necrosis factor-alpha-induced cell death. Biochem Biophys Res Commun 311: 518-524, 2003. (Pubitemid 37340110) (Instituto de Salud Carlos III)